Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
38.4M
-
Shares change
-
+22.1K
-
Total reported value, excl. options
-
$1.98B
-
Value change
-
+$14.5M
-
Put/Call ratio
-
0.48
-
Number of buys
-
104
-
Number of sells
-
-42
-
Price
-
$51.47
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q1 2019
192 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q1 2019.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.4M shares
.
Largest 10 shareholders include BlackRock Inc. (2.86M shares), STIFEL FINANCIAL CORP (2.83M shares), RP Management, LLC (2.11M shares), JPMORGAN CHASE & CO (1.77M shares), ALLIANCEBERNSTEIN L.P. (1.46M shares), WELLINGTON MANAGEMENT GROUP LLP (1.38M shares), STATE STREET CORP (1.34M shares), JANUS HENDERSON GROUP PLC (1.25M shares), VHCP Management II, LLC (1.14M shares), and Cormorant Asset Management, LP (1.1M shares).
This table shows the top 167 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.